Aug 9 |
Q2 2024 Ocugen Inc Earnings Call
|
Aug 8 |
Ocugen (OCGN) Q2 2024 Earnings Call Transcript
|
Aug 8 |
Ocugen, Inc. (OCGN) Q2 2024 Earnings Call Transcript
|
Aug 8 |
Ocugen GAAP EPS of -$0.04 beats by $0.01, revenue of $1.14M
|
Aug 8 |
Ocugen Provides Business Update with Second Quarter 2024 Financial Results
|
Aug 8 |
Ocugen: Q2 Earnings Snapshot
|
Aug 7 |
Ocugen Q2 2024 Earnings Preview
|
Aug 5 |
Ocugen, Inc. Announces FDA Approval of Expanded Access Program for Patients with Retinitis Pigmentosa
|
Aug 1 |
Why Ocugen (OCGN) Stock Is Falling
|
Aug 1 |
Ocugen dips 11%, issues $35M stock at $1.15 per share
|